Moreover, in vivo studies showed that CH-3 boosts the sensitivity of NSCLC cells to radiation [25], indicating that radiosensitizers targeting WDHD1 may provide an alternative approach to inhibit NSCLC progression. This evidence concerns the gene WDHD1 and non-small cell lung carcinoma.